The gut transit of T4 phages was studied in axenic mice mono-colonized with the non-pathogenic Escherichia coli strain K-12. Thirty minutes, 1 and 2 h after phage feeding, T4 phage had reached the jejunum, ileum and cecum, respectively. Phage was found in the lumen and was also associated with the mucosa. One day later no phage was detected in the feces. Compared to germ-free control animals, oral T4 phage led to a 300-fold higher fecal phage titer in mice mono-colonized with E. coli strain WG-5. The in vivo T4 phage replication was transient and reached peak fecal titers about 8 h after oral phage application followed by a rapid titer decrease over two days. Similar data were obtained in mice colonized with E. coli strain Nissle. In contrast, orally applied T7 phage experienced a massive and sustained in vivo replication in mice mono-colonized with E. coli strain WG-5 irrespective whether phage or E. coli host was applied first. T7 phage replication occurred mainly in the large intestine. High titers of T7 phage and high E. coli cell counts coexisted in the feces. The observation of only 20% T7 phage-resistant fecal E. coli colonies suggests a refuge model where phage-sensitive E. coli cells are physically or physiologically protected from phage infection in the gut. The difference between T7 and T4 with respect to gut replication might partly reflect their distinct in vitro capacity to replicate on slowly growing cells.
Introduction
Antibiotic-resistant bacteria have become such a serious problem in current medical practice (Furuya and Lowy, 2006 ) that governmental health agencies have issued research calls for alternative treatment options against bacterial infections (http://www.cihr-irsc. gc.ca/e/31302.html). From a conceptual point of view, one of the most promising alternative approaches is phage therapy (Brüssow, 2005; Merril et al., 2003) . In fact, phage preparations against diarrheal diseases and wound infections can be bought as registered over-thecounter medicine in Russian pharmacies. However, neither the microbiological characteristics of these phage preparations nor the clinical studies conducted with them were described in detailed recent scientific publications (Sulakvelidze et al., 2001) . Consequently, the treatment and prevention claims made for these phage preparations were regarded with substantial skepticism in the Western world, despite the fact that British and US veterinarians demonstrated the efficacy of oral phage against Escherichia coli diarrhea in calves (Smith and Huggins, 1983; Smith et al., 1987a,b) and respiratory E. coli infections in chicken (Huff et al., 2002) .
E. coli bacteriophage T4, a Myovirus, and T7, a Podovirus, are prototypes of professional "virulent" (i.e. lytic) phages, whose genomes are devoid of bacterial pathogenicity factors (Denou et al., 2009; Kwon et al., 2008; Miller et al., 2003; Zuber et al., 2007) . These phages are thus good candidates for phage therapy approaches against E. coli diarrhea in contrast to lambdoid coliphages, a temperate Siphovirus, which frequently carry bacterial virulence genes (Brüssow et al., 2004) .
Phage T4 and its host E. coli belong to the best-characterized interacting biological systems (Karam, 1994) . Despite decades of research in many laboratories, the phage infection process has with few exceptions (Chibani-Chennoufi et al., 2004b; Tanji et al., 2005; Weld et al., 2004) been studied with in vitro systems. Within the framework of the reductionist approach, researchers had no incentive to analyze the phage-bacterium interaction within the natural niche of E. coli, i.e. the colon of warm blooded animals. In addition to the complexity of the system, E. coli represents only a tiny fraction of the gut flora in mammals making the in vivo study of T4 phage-E. coli interactions technically demanding. Small laboratory animals like mice cannot be infected symptomatically with enteropathogenic E. coli (Mundy et al., 2006; Savkovic et al., 2005) excluding this option to increase the gut titer of E. coli. A colitis model using Citrobacter infection in mice (Borenshtein et al., 2008) or enterohemorrhagic E. coli strain O157:H7 in rabbits (Ritchie et al., 2003) are the nearest surrogates. To study phage-E. coli interaction in a mammal, we used germ-free mice that were mono-colonized with E. coli and which received T4 or T7 phage orally. We used for these experiments E. coli strains K-12, WG-5 or Nissle. K-12 was isolated from the stool of a human subject (Lederberg, 2004) and became the prototype laboratory E. coli strain. This sequenced strain lacks inducible prophages and virulence genes. WG5 is frequently used by phage ecologists as an indicator strain (Guzman et al., 2008) because it has a wider susceptibility to coliphages than K-12. E. coli strain Nissle was isolated from a healthy human subject (Nissle, 1918) . Due to its good gut colonization properties it became a well-known probiotic E. coli strain (Kruis et al., 2004) . We observed that the in vivo properties of E. coli phages T4 and T7 can only to a limited extent be predicted from their in vitro growth properties. These gaps in the understanding of bacterial host-phage interaction within the mammalian gut will not only limit the rational design of phage therapy approaches, but remind us about the gaps in our knowledge even with classical biological model systems.
Results
Bioavailability of oral T4 phage in the gut of mice mono-colonized with E. coli strain K-12
In germ-free mice, which were mono-colonized with the E. coli strain K-12, the highest bacterial titers were found in the cecum and colon. Intermediate titers were seen in the stomach, while only low titers were observed in the small intestine (Fig. 1A) . All colonies, which we recovered from the feces of these animals were in vitro susceptible to a wide range of T4 phages.
The mice were then force-fed with 5 × 10 4 pfu of T4 phages RB49 and RB69, representing two distinct subtypes of T4 coliphages (Comeau et al., 2007; Desplats et al., 2002; Nolan et al., 2006) . Groups of three mice were dissected in a time sequence to follow the transit of the phage through the gut as a function of time. Thirty minutes after oral phage application, the majority of the phage was located between the proximal jejunum and the proximal ileum. Phage was detected both in the lumen and in the mucosal scrapings ( Fig. 2A) . Thirty minutes later, the phage detection zone had shifted from the jejunum into the ileum, but phage
had not yet reached the cecum (Fig. 2B ). Two hours after phage feeding, the phage was found spread over the intestine and for the first time it was detected in the cecum and upper colon (Fig. 2C ). Four hours after inoculation, the phage had advanced into the large intestine, while the small intestine now lacked phage (Fig. 2D ). Mice are coprophageous (i.e. they eat their fecal material): the reappearance of phage in the stomach (Figs. 2C, D) therefore probably represents re-exposure to fecal phage from ingested stool pellets. One day after oral phage application, no fecal phage titer was measured. No significant phage amplification (defined as N10-fold titer increase over oral phage) was seen in any gut segment when phage concentrations or absolute phage titers accounting for the volumes of intestinal fluids were measured (data not shown). In addition, no significant decrease of intestinal E. coli titers was observed during the 4 h observation period (data not shown). It is premature to conclude that no phage replication has occurred in vivo. It remains possible that new phage was produced while oral phage was lost to inactivation in the gut by stomach acidity, bile acids or digestive enzymes.
Oral T4 phage in the gut of mice mono-colonized with E. coli strain WG-5 or Nissle
To control for loss of oral phage during gastrointestinal passage, we followed the fecal excretion pattern of 10 7 pfu of phage T4 given by intragastric application to six germ-free mice. Since no bacterial cells were present in the gut of these animals, the fecal recovery represents the passive transit of phage through the gut. Peak fecal titers of 6 × 10 5 pfu/g feces were observed 6 h after phage application.
Two days after application, fecal phage was not any longer detected (200 pfu/g was the sensitivity of our test for fecal samples, 50 pfu/ml for secretions of small intestine) (Fig. 3) . In the following experiment, five mice were first colonized with E. coli strain WG-5. When mice had achieved a stable fecal excretion level of 10 9 cfu/g feces indicating successful colonization, they received the same amount of T4 phage as in the previous experiment. Under these conditions, we observed a peak fecal phage titer of 10 8 pfu/g feces 8 h after phage application, indicating an about 300-fold titer increase over the peak phage titer in germ-free animals. However, this elevated phage titer was not maintained in the WG-5-colonized mice: it dropped below 10 5 pfu/g at 20 h after phage application (Fig. 3) . In the T4-fed mice the fecal WG-5 titers remained stable at 3 × 10 9 cfu/g (data not shown).
Very similar results were obtained with E. coli strain Nissle, which achieved an approximately 10-fold higher intestinal colonization level in mice than the K-12 strain. The Nissle strain was mainly found in the large intestine and the stomach, while the titers in the small intestine were low (compare Fig. 1B with Fig. 1A ). The Nissle strain was resistant to most phages from our T4 collection except T4-like phage isolate ED6. By intragastric application, T4 phage ED6 was first given to germ-free mice at a dose of 10 6 pfu. As these mice lacked intestinal bacteria, we observed again the passive transit of phage through the gut. Fecal phage titers reached peak titers at 6 to 12 h after oral application, subsequently phages dropped to low titers at 24 h ( Fig. 4 ) and were not detected any longer 48 h after feeding (data not shown). When 10 6 pfu of phage ED6 was given to mice, which were already mono-colonized with strain Nissle, about 50-fold higher fecal phage titers were observed (Fig. 4) suggesting in vivo phage replication. Despite the presence of target cells, phage replication was not maintained. Two days after oral phage application, fecal phage titers dropped below the detection limit (data not shown). Phage-treated mice did not differ from control mice for fecal E. coli titers over a two-week follow-up period (data not shown).
To explore the effect of a larger oral phage dose on fecal E. coli titers, we exposed Nissle-colonized mice to 10 8 pfu of phage ED6 by intragastric inoculation. Five hours after phage application, phagetreated mice showed decreased E. coli titers in the stomach and the proximal small intestine, while in the large intestine phage-treated and control mice showed similar E. coli titers (Fig. 1B ).
Search for factors that potentially limit in vivo T4 phage infection
In conventional mice we observed clusters of bacterial cells within the mucus overlaying the colonic epithelia (Figs. 5A, B) while only isolated bacterial cells were seen in Nissle-colonized mice (Fig .   Fig. 2 . Kinetics of the gastrointestinal phage T4 transit. 5 × 10 4 pfu of T4 phages RB69 and RB49 were applied to twelve mice, which were mono-colonized with E. coli strain K-12. The figure shows the phage titer expressed as log pfu/g in the specified gut segment (see Fig. 1 for location) of mice dissected after 30 min (A), 60 min (B), 120 min (C), and 240 min (D). The figure shows the titer of T4 phage from 3 mice shown as black, grey and white bars. applied by gastric feeding to six germ-free mice lacking bacteria in their gut (filled diamonds) and five mice mono-colonized with E. coli strain WG-5 (open diamonds). The fecal pfu titer (ordinate) was plotted against recovery time of the feces in hours (abscissa) after phage application. 5C). In K-12 colonized mice, no bacterial cells were detected microscopically in gut sections reflecting their lower gut colonization level. Within the mucus embedding, the intestinal E. coli cells might be physically shielded from phage infection. Alternatively, due to the low gut bacterial titers the E. coli cells might be protected by threshold phenomena. However, in phage-treated mice the colonassociated Nissle cells showed a rough cell envelope and some cells showed protruding membrane blobs (Fig. 5D ), which were not observed in control Nissle-colonized mice (Fig. 5C ). It is unclear whether these morphological changes are a consequence of phage infection. E. coli phage infections in the laboratory are normally conducted with well aerated cells, while no oxygen is found in the lumen of the colon. Therefore we tested whether the investigated T4 phages could infect E. coli under anaerobic in vitro conditions. This was the case: our T4 phages yielded in vitro similar titers under aerobic and anaerobic growth (data not shown). No phage-resistant E. coli strains were observed in mice exposed to T4 phage.
Massive intestinal replication of T7 coliphage in mice mono-colonized with E. coli strain WG-5
Mice mono-colonized with the E. coli indicator cell WG5 received then Podophage T7. In the first experiment, 10 6 pfu T7 was given intragastrically to germ-free mice. The T7 podophage was detected in the feces 6 to 12 h after application and became undetectable (b200 pfu/g) after a day (Fig. 6A ). Mice did not show changes in appearance, behavior or food intake after exposure to T7 phage. One week later these mice were colonized with E. coli strain WG5. Low amounts of this podophage must have persisted in the mice since we observed a rapid increase of the previously undetectable phage to titers of up to 10 10 pfu/g feces (Fig. 6B) . Interestingly, these high fecal phage titers coexisted with high fecal counts of E. coli strain WG5. We measured between 5 × 10 8 and 3 × 10 9 cfu of WG5 per g feces. When the observation period was extended to 24 days, phage counts in excess of 10 10 pfu/g feces and cell counts around 10 9 cfu/g feces were simultaneously measured in the fecal samples (Fig. 7) . Again, mice did not show changes in appearance, behavior or food intake during the observation period. In these mice bacteria were only detected in the cecum and the colon (Fig. 8A) . Phages showed high titers in the large intestine and much lower phage titers were observed in the stomach and small intestine (Fig. 8B) .
Coexisting high phage and bacterial titers were also observed when germ-free mice were first colonized with E. coli strain WG5 and only 3 days later orally exposed to 10 6 pfu T7 phage (data not shown).
Then we asked whether the fecal coexistence of E. coli and T7 phage was associated with the in vivo development of phage-resistant E. coli colonies. Indeed, six out of 30 random fecal E. coli colonies isolated from mice, which were treated with T7 phage, were resistant to in vitro infection with the parental podophage.
T7 shows better in vitro growth on late exponential/stationary cells than T4
WG-5 cells were grown in vitro and infected with T7 phage at 10 different time points representing early, middle, late exponential phases and transitions to stationary growth phase. The phage titer observed in the culture supernatant did not change substantially until the late exponential phase. In the transition to the stationary phase T7 phage titers dropped 10-fold compared to T4 phage which suffered a 1000-fold titer reduction (data not shown). We then infected parallel cultures of WG-5 cells with T7 or T4 phage at an OD of 0.8, 1.0 and 1.2, respectively. At these late time points of the bacterial growth phase, the addition of T4 phage did not decrease the OD of the infected bacterial culture. In contrast, infection of parallel cultures with T7 6 pfu of podophage T7 was applied to the stomach of 5 germ-free mice and the fecal excretion pattern of the phage (in pfu/g, ordinate) was followed over time (hours, abscissa). B. One week later 5 germ-free mice were mono-colonized with E. coli strain WG-5. The figure shows the fecal excretion pattern of 10 6 pfu podophage over time (hours after WG-5 cell addition). Fig. 7 . Coexistence of T7 podophage and E. coli strain WG-5 in the feces of five monocolonized mice. The fecal excretion pattern of T7 phage (open diamonds, "-" median in pfu/g displayed at the right ordinate) and E. coli strain WG-5 (filled circles, "-" median in cfu/g displayed at the left ordinate) was followed in the mice over 24 days (abscissa). When only one out of the five mice showed a cell titer, the value is displayed as a dotted horizontal line.
phage still induced an OD decrease to 0.2 (data not shown). In addition, late exponential T7-infected cells yielded at least 100-fold higher phage titers than T4-infected cells.
Discussion
Oral application of T4-like phages to conventional mice, germ-free mice and axenic mice mono-colonized with three different E. coli strains did not induce adverse effects confirming earlier animal (Chibani-Chennoufi et al., 2004b) and human safety studies (Bruttin and Brüssow, 2005) . In patients with E. coli diarrhea, two different populations of E. coli cells can be distinguished in the gut. On one side are the pathogenic EPEC and ETEC strains that transiently colonize the small intestine with high titers (Gorbach et al., 1971; Stintzig and Möllby, 1982 ; this might, however, not be the case for Salmonella infections potentially leading to threshold consequences for phage therapy approaches (Zuber et al., 2008) ). On the other side are the commensal E. coli strains that colonize the large intestine with small numbers. Pathogen-specific T4 phages can be isolated when using pathogenic E. coli strains for phage isolation and propagation (ChibaniChennoufi et al., 2004a) . However, these phages turned out to be rather strain-specific leading to coverage problems. When isolating phages on non-pathogenic indicator cells like K-12 lacking the O side chain of the LPS antigen, one can obtain T4 phages with broader host range (Chibani-Chennoufi et al., 2004a) . In vitro these T4 phages attack both pathogenic and non-pathogenic E. coli strains (Chibani-Chennoufi et al., 2004b) . The commensal E. coli population makes up only a tiny fraction of the human gut flora. It is unlikely that their reduction by species-specific phages would lead to a health problem. The situation is very different from the effect of broad spectrum antibiotics given to patients, which wipe out the very diverse gut flora favoring colonization with Clostridium difficile leading to serious health consequences. However, antibiotics are generally not prescribed against E. coli diarrhea (Djie-Maletz et al., 2008) . Children are treated with oral and if needed intravenous rehydration solution, eliminating the concern for this collateral damage. One might also consider another type of collateral damage in which a phage is used against target species A and the gut is also home for a target species B, which is also sensitive to this phage. The phage might amplify on species A (to high densities if A is common, e.g. ETEC infection) and wipe out species B (for example another commensal enterobacterium) even if B is rare and would not sustain phage growth by itself. However, during in vitro tests we have observed only few T4 phages that crossed species barriers (Zuber et al., 2008 ) and some reported cross-infections (e.g. between E. coli and Shigella, (Sulakvelidze et al., 2001) ) are less spectacular than the distinct genus names suggest. Shigella qualifies at best as a subspecies of E. coli.
However, for phage therapy purpose, oral phage must not only be safe, it must also demonstrate in vivo lytic activity. In conventional laboratory mice, which lacked E. coli in their intestine, T4 phage was not amplified in vivo and fecal bacterial counts were not reduced by oral T4 phage (Denou et al., 2009) in accordance with previous observations (Kasman, 2005) . When conventional mice were fed with E. coli strain K-12, orally applied T4 phage showed some in vivo replication in the small intestine (Denou et al., 2009 ). Here we demonstrate again transient in vivo replication of oral T4 phages (50-to 300-fold gut titer increase over controls) in axenic mice monocolonized with two different E. coli strains.
What might be the reasons for this relatively restricted in vivo replication potential of T4 phages in mono-colonized mice? Threshold phenomena have been discussed in the mathematically-oriented phage literature (Kasman et al., 2002) . However, this is an unlikely argument: in mono-colonized mice the bacterial counts in the large intestine were much higher than the critical density of 10 4 colonies per ml below which T4 phage does not replicate in vitro (Wiggins and Alexander, 1985) .
Water is re-adsorbed from the gut content in the colon and wet pellets are formed. With the decreasing water content, the spread of phage to the next target cell becomes diffusion limited. A further factor which could decrease phage infection is the location of the bacterial cells within the mucus layer. Mucus is a logical place for colonic bacteria since it represents a food basis for them (Wadolkowski et al., 1988) . Commensal bacteria in the colon might thus be physically protected against phage infection. Comparable situations of a spatial refuge for phage-sensitive bacteria have been described for starter bacteria enmeshed in the semisolid curd of the coagulating milk during cheese production (Bruttin et al., 1997) .
There might also be barriers to phage infection imposed by the physiological state of the target bacterium. Previous studies reported metabolically inactive E. coli cells in the gut lumen, while metabolically active E. coli cells were found in microcolonies within the mucus layer of the colon (Krogfelt et al., 1993; Poulsen et al., 1995) . In the laboratory many phages need actively replicating bacterial hosts for their multiplication: in vitro the T4 phage growth depended heavily on the synthetic capacity of the host translation machinery (Hadas et al., 1997) . Bacterial commensals in the colon might not replicate at sufficient speed to represent appropriate target cells for T4 phage amplification. We estimated that under steady state conditions, E. coli experienced in the colon approximately five rounds of replication during a day to replace the fecal bacterial loss compared with a much faster growth rate (20 min generation time) for E. coli in the laboratory.
The conclusion that E. coli in the large intestine of mice is not a target for oral phage cannot be generalized to other classes of coliphages. T7 podophage replicated to high titers on E. coli colonizing the large intestine. This strikingly distinct in vivo behavior of T7 and T4 phages might have an in vitro correlate. T7 phage can lyse E. coli strains that are in late exponential in vitro growth phase, which T4 is unable to do (I. Molineux, pers. communication). These observations concur with reports that T7 unlike T4 can grow in starved cells (Schrader et al., 1997) . The clearly distinct in vitro replication potential of T4 and T7 phages might thus at least partially explain the ability of T7 to multiply on intestinal E. coli cells.
We observed high intestinal phage T7 and high E. coli titers over the duration of the experiment (3 weeks). The observation of an about 30-fold higher phage than cell titer in the colon indicated that a substantial percentage of the colon-colonizing E. coli cells were infected at any moment and producing T7 phages. The coexistence of phage and its bacterial target suggests in the mouse gut a pool of uninfected, but phage-susceptible cells. We postulate that these cells are physically or physiologically protected from phage infection. This pool feeds susceptible bacteria into a physical compartment or a physiological state in the gut where they become infected and produce progeny phages. Phage-resistant fecal E. coli cells were also observed and represented a fifth of the intestinal cells. This percentage is very different from the chemostat experiments where over 99% of the cells are phage-resistant (Bohannan and Lenski, 2000; Mizoguchi et al., 2003) . The observation of 80% phage-sensitive cells supports the refuge idea as explanation (Schrag and Mittler, 1996) while the 1% of phage-sensitive cells in the chemostat experiments is better explained by a co-evolution of the phages with their hosts.
On the basis of the experiments with mono-colonized mice, one might deduce that an aggressively replicating phage such as T7 could prove to be more efficacious than T4 at treating diarrhea. However, preliminary experiments in five T7-treated mice, which were monocolonized with WG-5, showed a congestion of a confined segment of the small intestine in three mice. This observation could indicate an adverse reaction against the high level phage replication and the concomitant release of bacterial lysis products over a three week observation period. However, this interpretation should be seen with caution. The location of the phage replication is in the colon, which appeared macroscopically normal, while no phage replication occurred in the small intestine which lacked E. coli target cells. Furthermore, we lack dissection data from WG-5 colonized control animals to clearly associate the observed congestion with oral phage exposure. Germ-free animals are a delicate experimental model, where the gut morphology responds dramatically to colonization with microbes and many other frequently unidentified factors.
Beyond these considerations for phage therapy, the present study highlights another biological message. E. coli and T4 are one of the best-characterized interacting biological systems (Karam, 1994) . However, already at the next level of biological complexity, when T4 and E. coli are studied in their natural ecological setting (the gut of mammals), data are scarce and in vivo effects cannot be predicted from the well-investigated in vitro effects (Weld et al., 2004) . It might be time to break with the reductionist principle and investigate microbe-microbe interactions in complex systems using classics of microbiology like E. coli and its phages as research tools in these unchartered areas.
Materials and methods

Phages and cells
T4-like phages RB49 and RB69 were received from E. Kutter (Olympia College, Wa, USA) and T7 phage was received from M. de Paepe (INSERM, Paris, France) (De Paepe and Taddei, 2006) . We screened our T4 phage collection for an isolate growing on E. coli Nissle strain and we identified the T4-like phage ED6. The E. coli strain K-12 derivative K803 was received from E. Kutter (Olympia College, WA, USA), E. coli strain WG5 was received from J. Jofre (Barcelona Univ. Spain) and E. coli strain Nissle was isolated from the commercial Mutaflor product (Ardeypharm, Germany). Phages were propagated on the specified E. coli strain inoculated into LB broth. For aerobic growth the culture was agitated at 150 strokes per min, for anaerobic growth the culture was maintained in an anaerobic jar at 37°C. The lysate was cleared by centrifugation and passed through a 0.22 μm Millipore filter. The T4 phages were then collected by ultracentrifugation (35,000 ×g for 25 min) and suspended in Vittel mineral water (Nestlé) to the indicated concentration.
Animal experiments
Adult axenic C3H mice were separated into insulators. Animals were held under sterile conditions in a Makrolon type 2 cages maintained in a positive pressure isolator of the animal house. Mice were fed with sterilized 03-40 chow, drinking water consisted of sterilized Vittel mineral water with the indicated amount of filtersterilized phage preparation. The mineral water was changed every two days. The colonization of mice with the indicated E. coli strain was by intragastric force-feeding (50 μl of a suspension containing10 9 cfu/ ml). Daily fecal samples were investigated for E. coli titer by colony counts on LB agar plates. Feces were sampled several times a day directly from the hand-held animal into a sterile tube by gently pressing the abdomen of the animals to avoid contamination of the stool with bedding material or dripping from the water bottles. Fecal phage titers were determined by the double-layer agar plaque assay on LB agar. At the end of the experiment mice were sacrificed and standard gross anatomical examination was conducted. At the specified time points mice were anaesthetized with isoflurane and killed by bleeding. A blood sample was collected into a heparin tube. Liver and spleen were dissected as well as the stomach, duodenum, jejunum (2 segments), ileum (3 segments), cecum, and colon (2 segments). The stomach, cecum and colon contents were extracted and the small intestine content was recovered by washing with a syringe. After extraction and washing the mucosa layer was collected from all gut segments (except the cecum) by scraping. E. coli and the orally applied phages were counted by colony and plaque assay, respectively. The food intake, mobility, change in behavior and physical appearance of the mice were noted by the workers in the animal house. The gross anatomy of the gut and other vital internal organs was noted during the dissection of the mice.
Microscopy
The gut samples were fixed by incubation in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.0 containing 0.04% ruthenium red and incubated for 16 h at 4°C. The samples were washed three times in this buffer followed by an incubation in 2% osmium tetroxide in the same buffer for 2 h at room temperature. The samples were washed before dehydration in a series of solutions of increasing ethanol concentration from 50% to 100%. The samples were then embedded by three successive 16 h incubations at 4°C in Spurr 50% in ethanol, Spurr 75% in ethanol and finally Spurr 100%. This was then polymerized for 48 h at 70°C and semi-thin and ultra-thin sections were cut with a Reichert OMU2 ultra-microtome. Semi-thin sections were stained with a solution of 0.5% Toluidine Blue in 1% Borax in distilled water before examination in bright field light microscopy (Zeiss Axioplan II, magnification 400×). Ultra-thin sections (thickness, 70 nm) were examined in transmission electron microscopy (TEM) after staining in uranyl acetate/lead citrate (Philips CM12, 80 kV, magnification 128,000×).
